BSA Behavioral Health announced it is expanding its mental health services to include Spravato (esketamine) nasal spray, for ...

The CEO of GH Research, Dr. Velichka Valcheva, pointed out that the response addressed the FDA’s requests with comprehensive ...

The government has permitted Dr. Cameron Lacey, a psychiatrist, to prescribe psilocybin, a hallucinogenic compound found in ...

When COVID arrived early in 2020, pandemic restrictions made in-person mental health care difficult or impossible. Both ...

Earlier identification is also of interest due to the possibility that earlier intervention may be more effective with more ...

Depression is everywhere these days, but mental health professionals are not. Some alternative treatments that could help are ...

A phase 2 trial shows that a single dose of psilocybin provides lasting relief from symptoms of depression and anxiety. New ...

Deep transcranial magnetic stimulation was safe and effective in treating adolescents and young adults with major depressive ...

Introduction Major depressive disorder (MDD) is a major global healthcare challenge. This is, in part, due to the lack of treatment response and chronic course of MDD. Such a course of illness is ...

Compared with placebo, pramipexole added to antidepressants reduces symptoms significantly at 12 weeks in treatment-resistant ...

In a 28-day treatment regimen, ART12.11 significantly reversed behavioral impairments in male rats exposed to chronic stress. The compound improved sucrose preference and social motivation, ...